# A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine

> **NCT00001688** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 25 (—)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Ritonavir
- **DRUG:** Nevirapine
- **DRUG:** Stavudine

## Key facts

- **NCT ID:** NCT00001688
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** —
- **Final completion:** 2001-11
- **Target enrollment:** 25 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001688, "A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00001688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*